Every Type of Cosmetic Peptide Explained
Cosmetic Peptides
4 functional categories
Cosmetic peptides are classified into four categories based on their mechanism of action: signal, carrier, neurotransmitter-inhibiting, and enzyme inhibitor peptides.
Gorouhi et al., International Journal of Cosmetic Science, 2009
Gorouhi et al., International Journal of Cosmetic Science, 2009
View as imageThe cosmetics industry uses the word "peptide" to sell hundreds of products, but rarely explains what the peptides in those products actually do. There are over 100 commercially available cosmetic peptides, and they fall into four functional categories based on how they interact with skin cells: signal peptides that tell cells to produce more collagen, carrier peptides that deliver metal ions to skin, neurotransmitter-inhibiting peptides that relax facial muscles, and enzyme inhibitor peptides that block collagen breakdown.[1] Each category works through a different biological mechanism, and the evidence supporting each varies substantially. This article maps the entire landscape. For the pillar article on the most commercially successful cosmetic peptide, see our coverage of Argireline (Acetyl Hexapeptide-3).
Key Takeaways
- Cosmetic peptides are classified into four categories: signal peptides (stimulate collagen production), carrier peptides (deliver trace metals), neurotransmitter-inhibiting peptides (relax muscles), and enzyme inhibitor peptides (block collagen breakdown)
- Signal peptides like palmitoyl pentapeptide-4 (Matrixyl) and GHK-Cu are the most extensively studied category, with in vitro evidence showing increased collagen I, III, and fibronectin synthesis (Skibska et al., 2021)
- Neurotransmitter-inhibiting peptides like Argireline (acetyl hexapeptide-3) work by interfering with the SNARE complex that controls neurotransmitter release at the neuromuscular junction (Blanes-Mira et al., 2002)
- Carrier peptides are the smallest category, with GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) being the best-characterized example
- A 2025 review identified over 100 commercially available cosmetic peptides, with signal peptides comprising the largest proportion (Wang et al., 2025)
- The primary limitation across all categories is skin penetration: peptides are hydrophilic molecules that struggle to cross the stratum corneum without delivery-enhancing formulation strategies
The four-category classification system
The standard classification of cosmetic peptides into four functional categories was established in early reviews by Gorouhi et al. (2009) and refined by subsequent authors.[1][2] The system is organized by mechanism of action, not by chemical structure or peptide length.
| Category | Mechanism | Key Examples | Primary Skin Effect |
|---|---|---|---|
| Signal peptides | Stimulate fibroblast protein production | Matrixyl (pal-KTTKS), GHK, Tripeptide-1 | Increased collagen, elastin |
| Carrier peptides | Deliver metal ions to enzymatic sites | GHK-Cu, Manganese tripeptide-1 | Enhanced enzymatic repair |
| Neurotransmitter-inhibiting | Interfere with muscle contraction signaling | Argireline, SNAP-8, Leuphasyl | Reduced expression lines |
| Enzyme inhibitor | Block matrix metalloproteinases or other enzymes | Soy peptides, rice-derived peptides | Reduced collagen degradation |
This classification is useful but imperfect. Some peptides span categories. GHK-Cu functions as both a carrier peptide (delivering copper) and a signal peptide (directly stimulating collagen gene expression).[3] The boundaries between categories describe the primary mechanism, not the only one.
Signal peptides: telling cells to build
Signal peptides are the largest and most studied category. They work by mimicking fragments of extracellular matrix proteins, known as matrikines, that naturally signal fibroblasts to produce collagen, elastin, fibronectin, and other structural proteins.[4]
The concept is straightforward. When collagen is degraded by enzymes during normal skin turnover or UV damage, the resulting peptide fragments act as signals telling fibroblasts to synthesize replacement collagen. Synthetic signal peptides replicate this feedback loop by delivering the same molecular message without waiting for collagen breakdown to occur first.
Palmitoyl pentapeptide-4 (Matrixyl) is the most commercially successful signal peptide. It consists of the amino acid sequence KTTKS (lysine-threonine-threonine-lysine-serine) attached to a palmitic acid chain that improves skin penetration. The KTTKS sequence is a fragment of type I procollagen that was identified as a collagen synthesis stimulator. In vitro studies showed it increased production of collagen types I, III, and IV, as well as fibronectin, in human fibroblast cultures.[5] For a detailed analysis, see our Matrixyl article.
GHK (glycyl-L-histidyl-L-lysine) is a tripeptide naturally present in human plasma, saliva, and urine. Plasma levels decline with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. Pickart et al. (2012) documented that GHK stimulates collagen synthesis, promotes decorin production, and modulates the expression of over 4,000 human genes, including genes involved in tissue repair, immune function, and antioxidant defense.[3] GHK also functions as a carrier peptide when complexed with copper (see below). For a comprehensive look at copper peptides in skincare, see our dedicated article.
Tripeptide-1 (GHK without copper) and hexapeptide-9 are additional signal peptides with in vitro evidence supporting collagen stimulation. The number of commercially available signal peptides has grown rapidly, with Sirois et al. (2024) documenting the expanding matrikine landscape and its applications in dermatology and cosmetics.[4]
Limitations of signal peptides. The in vitro evidence for collagen stimulation is consistent, but translation to clinical wrinkle reduction in human skin is less certain. Fibroblast cultures receive peptides directly in solution. In actual skin, the peptide must penetrate the stratum corneum, survive enzymatic degradation, reach the dermis, and arrive at fibroblasts in sufficient concentration to trigger a response. Most clinical studies of signal peptides are manufacturer-sponsored, small, and short-term.
Carrier peptides: delivering metal ions
Carrier peptides stabilize and deliver trace elements, primarily copper, to skin cells where those metals serve as cofactors for enzymes involved in wound healing and tissue remodeling.[2]
GHK-Cu (copper tripeptide-1) is the defining member of this category. The GHK peptide has a strong natural affinity for copper(II) ions. When complexed with copper, it delivers the ion to cells that use it as a cofactor for lysyl oxidase (critical for collagen and elastin cross-linking), superoxide dismutase (antioxidant defense), and tyrosinase (melanin production). Pickart et al. documented that GHK-Cu promotes wound healing, increases collagen deposition, and enhances angiogenesis in animal models.[3]
Manganese tripeptide-1 is a less common carrier peptide that delivers manganese rather than copper. Manganese is a cofactor for superoxide dismutase 2 (the mitochondrial form), and the peptide is marketed for antioxidant protection of skin cells.
The carrier peptide category is the smallest of the four. Most carrier peptides are variants of the GHK sequence complexed with different metals. The evidence base is dominated by GHK-Cu research, and extending those findings to other carrier peptides requires caution.
Neurotransmitter-inhibiting peptides: the topical muscle relaxers
This category contains the most commercially visible cosmetic peptides after signal peptides. Neurotransmitter-inhibiting peptides work by interfering with acetylcholine release at the neuromuscular junction, reducing the muscle contractions that create expression wrinkles (forehead lines, crow's feet, frown lines).[6]
Acetyl hexapeptide-3 (Argireline) is the prototype. Developed by Lipotec (now part of Lubrizol), it is a synthetic hexapeptide that mimics the N-terminal end of SNAP-25, one of three proteins forming the SNARE complex. The SNARE complex is the molecular machinery that fuses neurotransmitter vesicles with the presynaptic membrane, allowing acetylcholine release. Blanes-Mira et al. (2002) demonstrated that acetyl hexapeptide-3 inhibited catecholamine release from chromaffin cells in a dose-dependent manner by competing with SNAP-25 for incorporation into the SNARE complex.[6] Our pillar article on Argireline covers the full evidence base.
Acetyl octapeptide-3 (SNAP-8) extends the Argireline concept with a longer peptide chain (eight amino acids rather than six), claiming improved SNARE complex inhibition. It targets the same mechanism but with a different binding profile. See our article on SNAP-8 for details.
Pentapeptide-18 (Leuphasyl) takes a different approach to the same goal. Rather than directly inhibiting the SNARE complex, it acts as an enkephalin mimetic that binds to opioid receptors on the presynaptic nerve terminal, reducing calcium influx and consequently decreasing acetylcholine release. The mechanism is indirect: instead of blocking the release machinery, it tells the nerve cell to release less neurotransmitter in the first place.
Pentapeptide-3 (Vialox) mimics the waglerin-1 peptide from temple viper venom (Tropidolaemus wagleri). It acts as a competitive antagonist at the nicotinic acetylcholine receptor on the muscle cell side of the neuromuscular junction, reversing the direction of inhibition compared to SNARE-targeting peptides. For a broader view of how these peptides work together, see our article on neurotransmitter-inhibiting peptides.
The central question for this entire category is penetration depth. Botulinum toxin works because it is injected directly into the muscle. Topical neurotransmitter-inhibiting peptides must cross the epidermis, reach the dermis, and arrive at the neuromuscular junction in sufficient concentration to compete with endogenous SNAP-25 or modulate acetylcholine release. No published study has demonstrated that topically applied Argireline or SNAP-8 reaches the neuromuscular junction in human skin at pharmacologically active concentrations.[7]
Enzyme inhibitor peptides: blocking collagen breakdown
Enzyme inhibitor peptides reduce the activity of matrix metalloproteinases (MMPs) and other enzymes that degrade collagen, elastin, and other structural proteins in the extracellular matrix.[1] While signal peptides tell cells to build more collagen, enzyme inhibitors try to preserve the collagen that already exists.
Soy-derived peptides are among the most studied natural enzyme inhibitors for cosmetic use. Soy proteins contain sequences that inhibit trypsin-like serine proteases and, in some formulations, have shown inhibition of MMP-1 (collagenase) in cell culture experiments. The active peptide sequences are typically produced by enzymatic hydrolysis of soy protein isolate.
Rice bran peptides contain sequences that inhibit MMP-1 and MMP-9 in fibroblast cultures, potentially reducing UV-induced collagen degradation. The evidence is primarily from in vitro studies using protein hydrolysates rather than defined synthetic peptides.
Acetyl tetrapeptide-9 is a synthetic enzyme inhibitor marketed for its ability to increase syndecan-1 expression, a proteoglycan that helps organize collagen fibrils in the dermis. It is positioned as preventing collagen disorganization rather than blocking collagen breakdown directly.
Dipeptide-2 targets a different enzyme entirely: angiotensin-converting enzyme (ACE). By inhibiting ACE locally, it is hypothesized to reduce fluid accumulation and improve lymphatic drainage, which is why it appears in eye creams targeting puffiness rather than in anti-wrinkle products. The theoretical link from ACE inhibition to visible eye-area improvement has limited clinical documentation.
This category has the weakest overall evidence base. Most enzyme inhibitor peptides are characterized through in vitro enzyme activity assays rather than clinical studies measuring skin outcomes. The jump from "inhibits MMP-1 in a test tube" to "reduces wrinkles on a face" involves assumptions about penetration, concentration, duration of contact, and competition with natural MMP regulators like tissue inhibitors of metalloproteinases (TIMPs).
The penetration problem across all categories
Every category of cosmetic peptide faces the same fundamental challenge: getting through the stratum corneum, the outermost layer of dead skin cells that serves as the skin's primary barrier.[7][8]
Peptides are hydrophilic molecules with molecular weights that typically exceed the 500 Dalton threshold considered the upper limit for passive diffusion through intact skin. A hexapeptide like Argireline has a molecular weight of approximately 889 Da. Even a tripeptide like GHK (340 Da) is at the edge of efficient passive penetration.
The cosmetics industry addresses this through several strategies:
Lipidation. Attaching a fatty acid chain (usually palmitic acid, C16) to the peptide's N-terminus increases lipophilicity and improves stratum corneum penetration. This is why many commercial cosmetic peptides carry a "palmitoyl" prefix: palmitoyl pentapeptide-4, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7. The palmitic acid acts as a molecular anchor that inserts into the lipid bilayers between corneocytes.
Acetylation. Adding an acetyl group to the N-terminus provides modest improvement in penetration and protects the peptide from aminopeptidase degradation. Acetyl hexapeptide-3 (Argireline) and acetyl octapeptide-3 (SNAP-8) use this approach.
Liposomal and nanoparticle delivery. Encapsulating peptides in liposomes, niosomes, or solid lipid nanoparticles can improve delivery past the stratum corneum. These technologies are increasingly common in premium products but add substantial formulation cost.
Despite these strategies, quantitative data on how much peptide actually reaches the target site (dermis for signal peptides, neuromuscular junction for neurotransmitter-inhibiting peptides) in human skin at cosmetically relevant concentrations remains sparse. Wang et al. (2025) noted this as the single largest gap in the cosmetic peptide evidence base.[8]
Comparing categories: which peptides have the strongest evidence?
The evidence quality varies dramatically between categories.
Signal peptides have the strongest mechanistic foundation. Collagen stimulation by matrikine fragments is a well-established biological phenomenon with multiple independent research groups confirming the basic mechanism in cell culture. The clinical translation evidence is moderate, with several randomized studies showing measurable improvements in wrinkle depth and skin roughness with products containing Matrixyl or GHK-Cu, though study sizes are typically small (20-40 participants) and durations short (8-12 weeks).[5]
Carrier peptides have a narrow but solid evidence base, essentially consisting of GHK-Cu research. Copper delivery to skin cells is a plausible mechanism supported by decades of wound healing research, though the translation from wound healing (damaged skin) to cosmetic improvement (intact aged skin) involves different biological contexts.[3]
Neurotransmitter-inhibiting peptides have a strong in vitro mechanism (SNARE complex inhibition is well-characterized) but the weakest evidence for topical delivery to the relevant target. The clinical data on whether peptide serums actually produce visible results remains limited and largely manufacturer-funded.
Enzyme inhibitor peptides have the weakest overall evidence base. Most are characterized only through in vitro enzyme assays, with minimal clinical data supporting visible skin improvements.
The Bottom Line
Cosmetic peptides fall into four functional categories: signal peptides that stimulate fibroblast protein production, carrier peptides that deliver metal ions, neurotransmitter-inhibiting peptides that reduce muscle contraction, and enzyme inhibitor peptides that block collagen degradation. Signal peptides (led by Matrixyl and GHK) and carrier peptides (led by GHK-Cu) have the strongest evidence bases, while neurotransmitter-inhibiting peptides face unresolved penetration questions and enzyme inhibitors remain largely confined to in vitro data. The universal challenge across all categories is achieving sufficient peptide concentration at the biological target site after topical application through intact human skin.